FDA Halts Rocket Pharma's Gene Therapy Trial After Patient Death
Rocket Pharmaceuticals' pivotal gene therapy trial for Danon disease has been put on hold by the FDA following a patient's death linked to complications from the therapy, prompting the company to review its safety protocols and extend its cash runway while in discussions with regulators.